You have 9 free searches left this month | for more free features.

selinexor

Showing 51 - 75 of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)

Recruiting
  • Multiple Myeloma
  • +6 more
  • Selinexor
  • +3 more
  • Tucson, Arizona
  • +9 more
Jan 5, 2022

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Selinexor
  • +2 more
  • Frankfurt am Main, Hessen, Germany
  • +2 more
Aug 1, 2021

Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in

Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
Aug 31, 2021

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • selinexor
  • Correlative studies
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Selinexor
  • +6 more
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

Recruiting
  • Myelofibrosis
  • Selinexor
  • Physician's Choice Treatment
  • Los Angeles, California
  • +41 more
Jan 30, 2023

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Selinexor
  • ICE Chemotherapy
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Multiple Myeloma Trial in Chengdu (Selinexor, Thalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Selinexor
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 13, 2021

Ovarian Cancer, Endometrial Cancer Trial in Middletown, Harrison, New York (Paclitaxel, Carboplatin, Selinexor)

Completed
  • Ovarian Cancer
  • Endometrial Cancer
  • Middletown, New Jersey
  • +2 more
Apr 22, 2021

Multiple Myeloma Trial in China (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Selinexor
  • +3 more
  • Changzhou, Jiangsu, China
  • +5 more
Jun 11, 2023

Prostate Cancer Trial in Houston (Selinexor)

Terminated
  • Prostate Cancer
  • Selinexor
  • Houston, Texas
    M.D. Anderson Cancer Center
Jan 7, 2021

Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Laboratory Biomarker Analysis
  • Selinexor
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 12, 2021

Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Selinexor
  • +6 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 18, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)

Completed
  • Dedifferentiated Liposarcoma
  • Selinexor
  • Placebo
  • Los Angeles, California
  • +70 more
Jan 5, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Ovarian Carcinoma, Endometrial Carcinoma, Cervical Carcinoma Trial in Belgium, Denmark (Selinexor)

Completed
  • Ovarian Carcinoma
  • +2 more
  • Selinexor
  • Leuven, Belgium
  • +3 more
Jan 13, 2021

Solid Tumor Trial in Canada, Denmark, United States (Selinexor, Acetaminophen)

Completed
  • Solid Tumor
  • Tampa, Florida
  • +5 more
Apr 6, 2021

Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)

Completed
  • Coronavirus Infection
  • Selinexor
  • Placebo
  • Los Angeles, California
  • +32 more
Oct 27, 2021

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Suzhou (Selinexor, Flu, CTX)

Recruiting
  • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
  • Selinexor
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 3, 2022

Cancer, Covid19, Respiratory Viral Infection Trial in Melbourne (Interferon alfa, Selinexor, Lenzilumab)

Recruiting
  • Cancer
  • +2 more
  • Interferon alfa
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2021

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Refractory Multiple Myeloma Trial in Spain (Selinexor, Daratumumab, Bortezomib)

Recruiting
  • Refractory Multiple Myeloma
  • Selinexor
  • +3 more
  • Badalona, Spain
  • +14 more
Feb 3, 2021

Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
Nov 24, 2020

Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)

Completed
  • Acute Myeloid Leukemia (AML)
  • Selinexor
  • +2 more
  • Los Angeles, California
  • +77 more
Jan 24, 2023